Saqib Islam
CIK 1575408 · Chief Executive Officer · last filed 2025-07-02
Saqib Islam is a Chief Executive Officer who has filed 50 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for SWTX, was dated Jul 2, 2025. Across all open-market trades the lifetime net is −$31.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.0K
4
50
-$31.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Executive Officer | 0 | $46.99 | $0 | -$31.21M | 25 | 2025-07-02 |
| SPRY | Director | — | $9.76 | — | $0 | 3 | 2025-06-27 |
| PASG | Director | 5,000 | $5.81 | $29.0K | $90.0K | 7 | 2025-05-30 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −954,869 | $0 | EDGAR |
| 2025-06-27 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | −79,756 | -$4.30M | EDGAR |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −29,328 | -$1.77M | EDGAR |
| 2025-02-19 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −10,672 | -$639.5K | EDGAR |
| 2025-02-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +72,123 | -$781.7K | EDGAR |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −48,000 | -$2.56M | EDGAR |
| 2025-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +74,834 | $0 | EDGAR |
| 2025-01-07 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −38,700 | -$1.49M | EDGAR |